What is the recommended management for a patient with type 1 diabetes mellitus?

Management of Type 1 Diabetes Mellitus

Insulin Therapy Regimen

Most patients with type 1 diabetes should be treated with multiple daily injections (MDI) of basal and prandial insulin (3-4 injections per day) or continuous subcutaneous insulin infusion (CSII), using insulin analogs rather than human insulins to reduce hypoglycemia risk. 1

Initial Insulin Dosing

• Start with a total daily dose (TDD) of 0.5 units/kg/day for metabolically stable patients, with an acceptable range of 0.4-1.0 units/kg/day 2
• Split the TDD as 50% basal insulin and 50% prandial insulin distributed across three meals 2
• Higher doses (approaching 1.0 units/kg/day or more) are required during puberty 1, 2
• Patients presenting with diabetic ketoacidosis require higher weight-based dosing than the standard 0.5 units/kg/day 2

Basal Insulin Selection

Use long-acting insulin analogs (glargine, detemir, or degludec) administered once daily at the same time each day. 2

• Long-acting analogs provide a flatter, more constant plasma insulin profile than NPH insulin and significantly reduce nocturnal hypoglycemia 2, 3
• These analogs reduce overall hypoglycemia risk, injection burden, and weight gain compared to NPH insulin 3, 4

Prandial Insulin Selection and Timing

Use rapid-acting insulin analogs (aspart, lispro, or glulisine) injected 0-15 minutes before meals. 1, 2

• Rapid-acting analogs have faster onset, higher peak, and shorter duration than regular human insulin, resulting in better postprandial glucose control and reduced hypoglycemia 2, 3
• Faster-acting insulin aspart provides superior postprandial glucose coverage compared to standard rapid-acting analogs 2
• Regular human insulin requires injection 30-45 minutes before meals and carries higher postprandial hypoglycemia risk due to its 6-8 hour duration 4, 5

Patient Education and Insulin Adjustment

Educate patients to match prandial insulin doses to carbohydrate intake, premeal blood glucose levels, and anticipated physical activity. 1

• Patients who master carbohydrate counting should receive education on fat and protein gram estimation 1
• More frequent self-monitoring of blood glucose is required during illness, exercise, or dose adjustments 2

Injection Technique

• Use preferred injection sites: abdomen, thigh, buttock, and upper arm 2
• Rotate injection sites to prevent lipohypertrophy 2
• Ensure all injections are subcutaneous, avoiding intramuscular delivery to reduce severe hypoglycemia risk 2

Insulin Pump Therapy (CSII)

• Consider automated insulin delivery (AID) systems for all adults with type 1 diabetes, as they improve time-in-range, lower HbA1c, and reduce hypoglycemia 2
• Hybrid closed-loop AID systems are superior to sensor-augmented pump therapy alone 2
• Patients successfully using CSII should maintain access to this therapy after age 65 1
• CSII offers modest advantages over MDI in lowering HbA1c and reducing severe hypoglycemia 2, 6

Glycemic Targets and Monitoring

• Target HbA1c < 7% (53 mmol/mol) for most nonpregnant adults 3
• Target fasting glucose range: 80-130 mg/dL 2
• For patients with premeal glucose values within target but HbA1c above target, monitor postprandial plasma glucose 1-2 hours after meals and treat to reduce values to < 180 mg/dL 1

Basal Insulin Titration

Re-evaluate basal insulin every 3 days based on fasting glucose patterns. 2

• Treatment plans should be reassessed every 3-6 months with adjustments based on insulin-taking behavior and cost considerations 2

Cardiovascular Risk Factor Management

• Maintain LDL cholesterol < 100 mg/dL (2.60 mmol/L), with therapeutic option < 70 mg/dL for high-risk patients 1
• Maintain blood pressure < 130/80 mm Hg 1
• Daily aspirin regimen lowers coronary heart disease risk by 20-25% 1
• Patients who smoke should quit to reduce cardiovascular disease and microvascular complications 1

Screening for Complications

• Dilated eye examinations annually starting 3-5 years after type 1 diabetes onset 1
• Screen for microalbuminuria to detect early nephropathy 1
• Screen for thyroid autoantibodies at diabetes diagnosis, measure TSH after metabolic control is established, and recheck every 1-2 years if normal 7
• Screen for celiac disease and other autoimmune conditions 7

Dietary Recommendations

• Limit daily fat intake to ≤ 30% of calories, with < 7% from saturated fat 1
• Limit sodium intake to ≤ 1,500 mg per day 1
• Consume at least 14 g fiber per 1,000 kcal and foods containing whole grains 1
• Eat at least 3 oz whole grains, 2 cups fruit, and 3 cups vegetables daily 1
• Monitor carbohydrate intake through counting, exchanges, or experience-based estimation 1

Hypoglycemia Management

• Teach patients signs and symptoms of hypoglycemia and management strategies 1
• Patients should always carry a source of sugar 1
• Keep glucagon at home 1
• Educate family members about hypoglycemia 1
• Consider sensor-augmented insulin pump therapy with threshold-suspend feature for nocturnal hypoglycemia 7

Lifestyle Modifications

• Exercise regularly 1
• Maintain healthy weight 1
• Limit alcohol consumption to moderate amounts 1
• Recognize effects of stress on blood glucose levels and manage stress 1
• Wear medical alert bracelet or necklace 1